PlexusDx partners with licensed compounding pharmacies to ensure each batch meets strict stability standards, and knowing how to store and monitor your medication helps maintain the therapeutic consistency your personalized protocol depends on
Based on the typical UK regulatory pathway, the most realistic timeline is: Late 2026 / early 2027: Eli Lilly expected to submit regulatory filings to the FDA and MHRA following completion of the remaining TRIUMPH Phase 3 readouts Late 2027 to mid-2028: Possible MHRA marketing authorisation, allowing private UK prescribing 2028 to 2029 onwards: Possible NHS availability following a NICE technology appraisal and NHS commissioning decisions Timelines may differ across the four UK nations, as Scotland, Wales, and Northern Ireland assess medicines separately through the Scottish Medicines Consortium (SMC), All Wales Medicines Strategy Group (AWMSG), and the Department of Health Northern Ireland respectively
Melanotan and Bacteriostatic Water Working with melanotan in a research setting will generally require researchers to reconstitute a lyophilized peptide powder into a solution before use
(Link) Fundraising Announcements : Note that these roundups are AI-generated for the newsletter
By asking patients about all sources of care, providers can identify potential gaps early
Better support Based in Cambridge, our customer & technical support teams are always on hand to help you with your research and answer any technical questions you have.